The Clinical Psychedelic Lab at Monash University

Australias first psychedelic laboratory, pioneering a rigorous program of research and training in psychedelic therapies. Led by Dr Paul Liknaitzky, the lab is focused on investigating novel applications for psychedelic therapies, translating evidence into best clinical practice, exploring and mitigating under-examined risks, delivering next-generation therapist training, and improving access and affordability. To follow our progress and stay up to date with announcements about our projects, please like this page, subscribe at our lab website (https://www.monash.edu/psychedelics), and follow our lab head, Dr. Paul Liknaitzky on Twitter/X (https://twitter.com/PLiknaitzky/)

Psychedelic research and psychedelic-assisted therapies

The clinical psychedelic lab at monash university operates in the Research industry.

The clinical psychedelic lab at monash university's revenue is 11m - 100m

The clinical psychedelic lab at monash university has 11 - 50 employees.